Karen Wernli to Breast Neoplasms
This is a "connection" page, showing publications Karen Wernli has written about Breast Neoplasms.
Connection Strength
6.318
-
Decision quality and regret with treatment decisions in women with breast cancer: Pre-operative breast MRI and breast density. Breast Cancer Res Treat. 2022 Aug; 194(3):607-616.
Score: 0.477
-
Trends in screening breast magnetic resonance imaging use among US women, 2006 to 2016. Cancer. 2020 12 15; 126(24):5293-5302.
Score: 0.423
-
Surveillance for second breast cancer events in women with a personal history of breast cancer using breast MRI: a systematic review and meta-analysis. Breast Cancer Res Treat. 2020 Jun; 181(2):255-268.
Score: 0.410
-
Knowledge and Perception of Breast Density, Screening Mammography, and Supplemental Screening: in Search of "Informed". J Gen Intern Med. 2020 06; 35(6):1654-1660.
Score: 0.399
-
Patterns of Breast Imaging Use Among Women with a Personal History of Breast Cancer. J Gen Intern Med. 2019 10; 34(10):2098-2106.
Score: 0.391
-
Surveillance Breast MRI and Mammography: Comparison in Women with a Personal History of Breast Cancer. Radiology. 2019 08; 292(2):311-318.
Score: 0.386
-
From Principles to Practice: Real-World Patient and Stakeholder Engagement in Breast Cancer Research. Perm J. 2018; 22:17-232.
Score: 0.350
-
Change in Breast Cancer Screening Intervals Since the 2009 USPSTF Guideline. J Womens Health (Larchmt). 2017 08; 26(8):820-827.
Score: 0.329
-
Patterns of breast magnetic resonance imaging use in community practice. JAMA Intern Med. 2014 Jan; 174(1):125-32.
Score: 0.265
-
Timing of follow-up after abnormal screening and diagnostic mammograms. Am J Manag Care. 2011 Feb; 17(2):162-7.
Score: 0.217
-
Use of antidepressants and NSAIDs in relation to mortality in long-term breast cancer survivors. Pharmacoepidemiol Drug Saf. 2011 Feb; 20(2):131-7.
Score: 0.213
-
Antidepressant medication use and breast cancer risk. Pharmacoepidemiol Drug Saf. 2009 Apr; 18(4):284-90.
Score: 0.191
-
Reassessing the Benefits and Harms of Risk-Reducing Medication Considering the Persistent Risk of Breast Cancer Mortality in Estrogen Receptor-Positive Breast Cancer. J Clin Oncol. 2023 Feb 01; 41(4):859-870.
Score: 0.123
-
Women's Breast Cancer Screening Confidence by Screening Modality and Breast Density: A Breast Cancer Surveillance Consortium Survey Study. J Womens Health (Larchmt). 2022 11; 31(11):1547-1556.
Score: 0.122
-
Trends in Annual Surveillance Mammography Participation Among Breast Cancer Survivors From 2004 to 2016. J Natl Compr Canc Netw. 2022 04; 20(4):379-386.e9.
Score: 0.117
-
Preoperative MRI in breast cancer: effect of breast density on biopsy rate and yield. Breast Cancer Res Treat. 2022 Jan; 191(1):177-190.
Score: 0.114
-
Women's considerations and experiences for breast cancer screening and surveillance during the COVID-19 pandemic in the United States: A focus group study. Prev Med. 2021 10; 151:106542.
Score: 0.111
-
Assessment of a Risk-Based Approach for Triaging Mammography Examinations During Periods of Reduced Capacity. JAMA Netw Open. 2021 03 01; 4(3):e211974.
Score: 0.109
-
Facility Variability in Examination Indication Among Women With Prior Breast Cancer: Implications and the Need for Standardization. J Am Coll Radiol. 2020 Jun; 17(6):755-764.
Score: 0.101
-
Preoperative breast MRI and mortality in older women with breast cancer. Breast Cancer Res Treat. 2018 Jul; 170(1):149-157.
Score: 0.089
-
Underutilization of Supplemental Magnetic Resonance Imaging Screening Among Patients at High Breast Cancer Risk. J Womens Health (Larchmt). 2018 06; 27(6):748-754.
Score: 0.088
-
Preoperative Breast Magnetic Resonance Imaging Use by Breast Density and Family History of Breast Cancer. J Womens Health (Larchmt). 2018 08; 27(8):987-993.
Score: 0.088
-
Relationship between preoperative breast MRI and surgical treatment of non-metastatic breast cancer. J Surg Oncol. 2017 Dec; 116(8):1008-1015.
Score: 0.087
-
Performance Benchmarks for Screening Breast MR Imaging in Community Practice. Radiology. 2017 10; 285(1):44-52.
Score: 0.084
-
A web-based personalized risk communication and decision-making tool for women with dense breasts: Design and methods of a randomized controlled trial within an integrated health care system. Contemp Clin Trials. 2017 05; 56:25-33.
Score: 0.082
-
Breast MRI in the Diagnostic and Preoperative Workup Among Medicare Beneficiaries With Breast Cancer. Med Care. 2016 07; 54(7):719-24.
Score: 0.079
-
Costs of diagnostic and preoperative workup with and without breast MRI in older women with a breast cancer diagnosis. BMC Health Serv Res. 2016 Feb 27; 16:76.
Score: 0.077
-
Concordance of BI-RADS Assessments and Management Recommendations for Breast MRI in Community Practice. AJR Am J Roentgenol. 2016 Jan; 206(1):211-6.
Score: 0.076
-
Disparities in the use of screening magnetic resonance imaging of the breast in community practice by race, ethnicity, and socioeconomic status. Cancer. 2016 Feb 15; 122(4):611-7.
Score: 0.076
-
Breast Cancer Characteristics Associated With Digital Versus Film-Screen Mammography for Screen-Detected and Interval Cancers. AJR Am J Roentgenol. 2015 Sep; 205(3):676-84.
Score: 0.074
-
Shift work and breast cancer among women textile workers in Shanghai, China. Cancer Causes Control. 2015 Jan; 26(1):143-50.
Score: 0.071
-
Breast MRI BI-RADS assessments and abnormal interpretation rates by clinical indication in US community practices. Acad Radiol. 2014 Nov; 21(11):1370-6.
Score: 0.069
-
Occupational exposure to magnetic fields and breast cancer among women textile workers in Shanghai, China. Am J Epidemiol. 2013 Oct 01; 178(7):1038-45.
Score: 0.065
-
Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age. Cancer. 2013 Nov 15; 119(22):3959-67.
Score: 0.065
-
Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy. JAMA Intern Med. 2013 May 13; 173(9):807-16.
Score: 0.063
-
Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates? J Natl Cancer Inst. 2013 Mar 06; 105(5):334-41.
Score: 0.062
-
The impact of obesity on follow-up after an abnormal screening mammogram. Cancer Epidemiol Biomarkers Prev. 2012 Feb; 21(2):327-36.
Score: 0.057
-
Occupational exposures and breast cancer among women textile workers in Shanghai. Epidemiology. 2007 May; 18(3):383-92.
Score: 0.042
-
Development of a cancer research study in the Shanghai textile industry. Int J Occup Environ Health. 2003 Oct-Dec; 9(4):347-56.
Score: 0.033
-
Prior breast density awareness, knowledge, and communication in a health system-embedded behavioral intervention trial. Cancer. 2020 04 15; 126(8):1614-1621.
Score: 0.025
-
Multilevel factors associated with long-term adherence to screening mammography in older women in the U.S. Prev Med. 2016 08; 89:169-177.
Score: 0.020